Abstract PD3-09: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2- positive metastatic breast cancer: Results from the EORTC 75111- 10114 ETF/BCG randomized phase II study
H Wildiers
◽
K Tryfonidis
◽
L dal Lago
◽
P Vuylsteke
◽
G Curigliano
◽
...